FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W7609251> ?p ?o ?g. }

• W7609251 endingPage "7" @default.
• W7609251 startingPage "923" @default.
• W7609251 abstract "To investigate the prognostic value of interim and post-therapy PET-CT in patients with diffuse large B-cell lymphoma.A retrospective analysis was conducted on data from 116 patients with newly diagnosed diffuse large B-cell lymphoma. 43 patients underwent interim PET-CT after 4 cycles of chemotherapy, 48 patients underwent post-therapy PET-CT after 6-8 cycles of chemotherapy, and 25 patients underwent both interim PET-CT and post-therapy PET-CT. The patients were divided into three groups: complete response group, partial response group and no response group. The therapeutic response was assessed by comparing with baseline PET-CT. PET-CT status was assessed for its ability to predict progression-free survival (PFS) and overall survival (OS). The 2-year PFS rate and 3-year OS rate were evaluated using chi-square test. PFS and OS were estimated according to the Kaplan-Meier method and survival curves were compared by log-rank test.Interim PET-CT: The interim PET-CT findings of 42 patients were judged as complete response, 15 were judged as partial response, and the rest 11 were judged as no response. The 2-year PFS rates of the complete response group, partial response group and no response group were 61.9%, 60.0%, and 18.2%, respectively, and the 3-year OS rates were 52.4%, 46.7% and 9.1%, respectively. There were no significant differences between the complete response group and partial response group in 2-year PFS rate and 3-year OS rate (P > 0.05 for both). But there was a significant difference between the partial response group and no response group (P < 0.05). The post-therapy PET-CT findings of 50 patients was judged as complete response, 11 as partial response, and the rest 12 were judged as no response. The 2-year PFS rate of the complete response group, partial response group and no response group were 82.0%, 45.5%, and 8.3%, respectively, and the 3-year OS rates were 88.0%, 54.5%, and 8.3%, respectively. There were significant differences between the complete response group and partial response group in 2-year PFS rate and 3-year OS rate (P < 0.05), and there was a significant difference between the partial response group and no response group (P < 0.05).Compared with the interim PET-CT, post-therapy PET-CT can accurately evaluate the prognosis of patients with DLBCL. Interim PET-CT cannot define the prognosis of the complete response and partial response patients." @default.
• W7609251 created "2016-06-24" @default.
• W7609251 creator A5007319460 @default.
• W7609251 creator A5011372918 @default.
• W7609251 creator A5019330832 @default.
• W7609251 creator A5048781926 @default.
• W7609251 creator A5064931494 @default.
• W7609251 creator A5075777586 @default.
• W7609251 date "2014-12-01" @default.
• W7609251 modified "2023-09-24" @default.
• W7609251 title "[Prognostic value of PET-CT in patients with diffuse large B-cell lymphoma]." @default.
• W7609251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25623768" @default.
• W7609251 hasPublicationYear "2014" @default.
• W7609251 type Work @default.
• W7609251 sameAs 7609251 @default.
• W7609251 citedByCount "0" @default.
• W7609251 crossrefType "journal-article" @default.
• W7609251 hasAuthorship W7609251A5007319460 @default.
• W7609251 hasAuthorship W7609251A5011372918 @default.
• W7609251 hasAuthorship W7609251A5019330832 @default.
• W7609251 hasAuthorship W7609251A5048781926 @default.
• W7609251 hasAuthorship W7609251A5064931494 @default.
• W7609251 hasAuthorship W7609251A5075777586 @default.
• W7609251 hasConcept C10515644 @default.
• W7609251 hasConcept C126322002 @default.
• W7609251 hasConcept C166957645 @default.
• W7609251 hasConcept C167135981 @default.
• W7609251 hasConcept C2776694085 @default.
• W7609251 hasConcept C2776957806 @default.
• W7609251 hasConcept C2778559949 @default.
• W7609251 hasConcept C2779338263 @default.
• W7609251 hasConcept C2780739268 @default.
• W7609251 hasConcept C2989005 @default.
• W7609251 hasConcept C3019096185 @default.
• W7609251 hasConcept C66339696 @default.
• W7609251 hasConcept C71924100 @default.
• W7609251 hasConcept C95457728 @default.
• W7609251 hasConceptScore W7609251C10515644 @default.
• W7609251 hasConceptScore W7609251C126322002 @default.
• W7609251 hasConceptScore W7609251C166957645 @default.
• W7609251 hasConceptScore W7609251C167135981 @default.
• W7609251 hasConceptScore W7609251C2776694085 @default.
• W7609251 hasConceptScore W7609251C2776957806 @default.
• W7609251 hasConceptScore W7609251C2778559949 @default.
• W7609251 hasConceptScore W7609251C2779338263 @default.
• W7609251 hasConceptScore W7609251C2780739268 @default.
• W7609251 hasConceptScore W7609251C2989005 @default.
• W7609251 hasConceptScore W7609251C3019096185 @default.
• W7609251 hasConceptScore W7609251C66339696 @default.
• W7609251 hasConceptScore W7609251C71924100 @default.
• W7609251 hasConceptScore W7609251C95457728 @default.
• W7609251 hasIssue "12" @default.
• W7609251 hasLocation W76092511 @default.
• W7609251 hasOpenAccess W7609251 @default.
• W7609251 hasPrimaryLocation W76092511 @default.
• W7609251 hasRelatedWork W1501977161 @default.
• W7609251 hasRelatedWork W1526303459 @default.
• W7609251 hasRelatedWork W16338240 @default.
• W7609251 hasRelatedWork W1747630739 @default.
• W7609251 hasRelatedWork W2010108411 @default.
• W7609251 hasRelatedWork W2401589591 @default.
• W7609251 hasRelatedWork W2584579062 @default.
• W7609251 hasRelatedWork W2596897839 @default.
• W7609251 hasRelatedWork W2762537384 @default.
• W7609251 hasRelatedWork W7609251 @default.
• W7609251 hasVolume "36" @default.
• W7609251 isParatext "false" @default.
• W7609251 isRetracted "false" @default.
• W7609251 magId "7609251" @default.
• W7609251 workType "article" @default.